Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Clinical Trial of 13-Valent Pneumococcal Conjugate Vaccine — Stella

Home/Pneumococcal Infectious Disease/Clinical Trial of 13-Valent Pneumococcal Conjugate Vaccine

View on ClinicalTrials.gov

Recruiting

Back to Pneumococcal Infectious Disease trials

Clinical Trial of 13-Valent Pneumococcal Conjugate Vaccine

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(1 site)

China

Henan Provincial Center for Disease Control and Prevention, Zhengzhou, Henan

Key details

Phase

Large-scale testing

Sponsor

Sinovac Life Sciences Co., Ltd.

Enrollment target

~3,080 participants

Started

October 2024

Primary completion

May 2026

Age range

6 Weeks – 5 Years

Last updated January 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.